EVEROLIMUS for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 43 adverse event reports in the FDA FAERS database where EVEROLIMUS was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for EVEROLIMUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 5,090 | 12.8% | 5,065 | 421 |
| Malignant neoplasm progression | 3,789 | 9.6% | 1,120 | 1,076 |
| Diarrhoea | 3,061 | 7.7% | 357 | 1,273 |
| Fatigue | 2,946 | 7.4% | 348 | 975 |
| Stomatitis | 2,692 | 6.8% | 203 | 621 |
| Nausea | 2,079 | 5.2% | 222 | 880 |
| Dyspnoea | 1,925 | 4.9% | 424 | 1,072 |
| Drug ineffective | 1,837 | 4.6% | 251 | 398 |
| Pyrexia | 1,664 | 4.2% | 242 | 1,072 |
| Decreased appetite | 1,633 | 4.1% | 223 | 682 |
| Rash | 1,603 | 4.0% | 127 | 323 |
| Vomiting | 1,575 | 4.0% | 230 | 862 |
| Malaise | 1,545 | 3.9% | 230 | 674 |
| Weight decreased | 1,536 | 3.9% | 230 | 635 |
| Cough | 1,480 | 3.7% | 199 | 657 |
Other Indications for EVEROLIMUS
Product used for unknown indication (9,230)
Breast cancer (4,442)
Breast cancer metastatic (2,751)
Renal cancer (1,989)
Immunosuppressant drug therapy (1,847)
Renal transplant (1,604)
Renal cell carcinoma (1,573)
Neuroendocrine tumour (1,284)
Prophylaxis against transplant rejection (862)
Angiomyolipoma (794)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)